Cargando…
New treatment guidelines on Cushing's disease
It is important to treat patients with Cushing's disease as rapidly as possible to limit its long-term mortality and morbidity. Selective transphenoidal pituitary adenomectomy remains the treatment of choice but, unfortunately, the rate of cure at long-term follow-up is suboptimal and recurrenc...
Autores principales: | Arnaldi, Giorgio, Boscaro, Marco |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medicine Reports Ltd
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2948319/ https://www.ncbi.nlm.nih.gov/pubmed/20948716 http://dx.doi.org/10.3410/M1-64 |
Ejemplares similares
-
Clinical use of pasireotide for Cushing’s disease in adults
por: Ceccato, Filippo, et al.
Publicado: (2015) -
The medical treatment with pasireotide in Cushing’s disease: an Italian multicentre experience based on “real-world evidence”
por: Pivonello, Rosario, et al.
Publicado: (2019) -
Clinical Guidelines for the Diagnosis and Treatment of Cushing's Disease in Korea
por: Hur, Kyu Yeon, et al.
Publicado: (2015) -
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
por: Biller, Beverly MK, et al.
Publicado: (2010) -
Treatment Options in Cushing’s Disease
por: Rizk, Ahmed, et al.
Publicado: (2012)